Market Access Strategy Postdoctoral Research Fellow

About the role

The two‑year North American Commercial—US Market Access Strategy fellowship supports payer marketing and strategy across Vertex’s commercial and pipeline portfolio. Fellows work closely with cross‑functional teams to develop launch and lifecycle access plans for high‑impact therapeutic areas.

Key responsibilities

• Build foundational knowledge of U.S. market access dynamics, including payer, policy, and reimbursement factors.
• Advance strategic projects that strengthen launch and lifecycle market access planning for disease areas such as Type 1 Diabetes, Pain, IgA Nephropathy, APOL1‑Mediated Kidney Disease, and Cystic Fibrosis.
• Identify innovative partnerships, market disruptors, and policy changes to enhance compliant patient access and payer engagement.
• Contribute to payer value propositions, access narratives, and strategic recommendations that support coverage optimization and differentiated product positioning.
• Create educational materials that communicate market access strategy to internal and external stakeholders.

Required profile

• Doctor of Pharmacy (Pharm.D.) degree from an ACPE‑accredited institution.
• Eligibility for pharmacist licensure in the State of Massachusetts.
• Excellent oral and written communication skills with strong time‑management and leadership abilities.
• Ability to work independently, manage multiple projects, and take initiative in a fast‑paced, launch‑oriented environment.

Required skills

• Demonstrated interest in U.S. payer policy, market access strategy, and health economics.
• Familiarity with the U.S. healthcare system, including formulary decision‑making processes.
• Self‑starter mindset with business acumen and agility to thrive in a launch‑focused setting.

What we offer

• Comprehensive benefits package including medical, vision, dental, paid time off, tuition assistance, wellness, retirement, and commuting support.
• Professional development through collaboration with Vertex’s biopharmaceutical partners and Northeastern University faculty.